Category Archives: HIV/AIDS

  1. Challenges for HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men in the United States

    via PLoS Medicine, by Gordon Mansergh, Beryl A. Koblin, Patrick S. Sullivan Summary Points: Pre-exposure prophylaxis (PrEP) with anti-retroviral (ARV) medications is partially efficacious for preventing HIV infection among men who have sex with men (MSM) and heterosexuals. As PrEP becomes available and prescribed for use among MSM a better understanding of willingness to use PrEP and Read More >>

    antiretroviral therapy, ARV, condoms, heterosexuality, HIV, hiv prevention, HIV transmission, HIV/AIDS, MSM, pre-exposure prophylaxis, PrEP
  2. Sustainable HIV prevention possibilities present choices, challenges

    via Science Speaks, by Antigone Barton When he looks at what biomedical science can do in the next decade to prevent HIV transmission, Jim Turpin of the National Institutes of Health said, he thinks of the lyrics of a Timbuk3 song: “The future’s so bright I gotta wear shades.” By, which, actually, he means — don’t get Read More >>

    antiretroviral therapy, AVAC, HIV, hiv prevention, HIV transmission, HIV/AIDS, IRMA, Microbicides, rectal microbicide, vaccine
  3. Policy Implications of The Lancet MSM & HIV Series

    via Center for Strategic & International Studies In light of the need to address key populations in the HIV epidemic, the Center for Strategic and International Studies is convening several authors to discuss a special issue of The Lancet focused on the global HIV epidemic among men who have sex with men (MSM). Thursday, September 6th3:00pm—5:00pm (EST)B1 Conference Read More >>

    HIV, HIV transmission, HIV/AIDS, MSM, The Lancet
  4. The HIV Prevention Pipeline: A Future of Possibilities

    via IRMA/AVAC, presented by Jim A. Turpin Please register for this teleconference.  Meeting Description: In the last two years there has been great progress in ARV-based prevention strategies – both in terms of PrEP and microbicides. Specifically, there has been enormous excitement and promise around two drugs – tenofovir and Truvada. And more recently, studies testing Dapivirine Read More >>

    ARV, AVAC, HIV, hiv prevention, HIV/AIDS, IRMA, maraviroc, Microbicides, NIH, PrEP, rectal microbicide, Tenofovir, Truvada
  5. Translating clinical efficacy into public health effectiveness

    via Citizen News Service, by Bobby Ramakant At the recently concluded XIX International AIDS Conference (AIDS 2012), not only the decibels went up on ending AIDS but also sane voices were heard demanding a well-costed and thought-through strategy on how to end AIDS. One of the strategies that will complement a comprehensive HIV prevention, treatment, care and Read More >>

    AIDS 2012, AVAC, condoms, FDA, HIV, hiv prevention, HIV transmission, HIV/AIDS, International AIDS Conference, IRMA, MTN, MTN 017, PrEP, rectal microbicide, risk, STI, Treatment, Treatment as Prevention, Truvada
  6. Community engagement is key as rectal microbicides research progresses ahead

    via Citizen News Service, by Bobby Ramakant While interviewing a range of experts involved with research, development and advocacy of new HIV prevention tools at the recently concluded XIX International AIDS Conference (AIDS 2012), I was reminded of a transgender woman who had said to me in an interview four years back that: “There is no doubt Read More >>

    AIDS 2012, Citizen News Service, HIV, hiv prevention, HIV/AIDS, International AIDS Conference, IRMA, lubricant, MSM, MTN, MTN 017, rectal microbicide, transgendered
  7. Anal health is not just a gay issue: Women need rectal microbicides too

    via Citizen News Service, by Bobby Ramakant “It is high time that anal health and hygiene comes out of the closet” said Dr Ross Cranston from University of Pittsburgh, USA. Dr Cranston was referring to the multitude of anal health complications people practicing receptive anal sex are likely to be dealing with in their lives and very Read More >>

    Africa, AIDS 2012, anal sex, Citizen News Service, herpes, HIV, hiv prevention, HIV/AIDS, International AIDS Conference, IRMA, Project ARM, rectal microbicide, STI, women, Women's Health
  8. What kind of prevention do gay men need?

     via aidsmap, by Gus Cairns How do we stop the hyperepidemic in gay men? A number of presentations at the 19th International AIDS Conference explored the ‘hyperepidemic’ of HIV amongst men who have sex with men, and especially black MSM. A paper presented by Gregorio Millet (pictured above at a White House reception honoring people working in AIDS) showed that, at Read More >>

    AIDS 2012, anal sex, antiretroviral therapy, ARVs, gay men, HIV, hiv prevention, HIV transmission, HIV/AIDS, International AIDS Conference, MSM, pre-exposure prophylaxis, PrEP, Treatment as Prevention
  9. Most young Thai MSM define as heterosexual, even if they mainly have sex with men

    via aidsmap, by Gus Cairns A large, randomised sample of 21-year-old Thai men, presented at the 19th International AIDS Conference in Washington recently, has found that by far the largest risk factor for HIV infection is gay identity. Contrary to the oft-quoted saying “it’s not who you are, but what you do,” actual male/male sexual behaviour, while Read More >>

    AIDS 2012, Gay, HIV, hiv prevention, HIV transmission, HIV/AIDS, International AIDS Conference, MSM, risk, Thailand
  10. Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults

    via Morbidity and Mortality Weekly Report In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009 (1). Of these, 27% were in heterosexual men and women who did not inject drugs, and 64% were in men who have sex with men (MSM), including 3% in MSM who inject drugs. In January Read More >>

    antiretroviral therapy, ARVs, CDC, FDA, Gilead, heterosexuality, HIV, hiv prevention, HIV transmission, HIV/AIDS, iPrEx, MSM, PrEP, risk, Tenofovir, Truvada